[PTCA]

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Acute Coronary Syndromes

Context:

• Primary percutaneous coronary intervention (PTCA) is a key treatment for acute myocardial infarction (AMI).
• Fibrinolysis has been a comparator treatment for AMI, with varying outcomes.
• Non-ST elevation acute coronary syndrome (NSTE-ACS) also presents challenges requiring intervention.

Purpose:

• To evaluate the effectiveness of primary PTCA in reducing mortality, reinfarction, and stroke post-AMI.
• To assess the impact of hospital delay on in-hospital mortality for primary PTCA.
• To explore the role of PTCA in managing NSTE-ACS and associated ischemic complications.

Summary:

• Primary PTCA demonstrated superior outcomes compared to fibrinolysis for AMI, reducing death, reinfarction, and stroke at discharge or 30 days.
• In-hospital mortality increased significantly with longer door-to-balloon times, highlighting the need for rapid intervention.
• While PTCA relieved chest pain and ischemia in NSTE-ACS, significant ischemic complications necessitated further medical stabilization and advancements like stents and antithrombotics.

Impact:

• Establishes primary PTCA as a preferred reperfusion strategy for AMI, emphasizing time sensitivity.
• Underscores the importance of reducing door-to-balloon times to improve survival rates.
• Identifies limitations of early PTCA in NSTE-ACS and the subsequent need for improved adjunctive therapies and devices.